Directors Dealings

Under section 15 a of the German Securities Trading Act, the members of the Executive and Supervisory Boards of SYGNIS Pharma AG and other executives of the Company are required to report the purchase or sale of SYGNIS shares. Such transactions will be reported at this page.

No reported transactions by directors in accordance with § 15a of the Securities Trade Act (WpHG) in fiscal year 2009/2010 or thereafter.